Plexus Corp. (NASDAQ:PLXS – Get Free Report) insider Frank Zycinski sold 1,200 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $140.84, for a total transaction of $169,008.00. Following the transaction, the insider now owns 723 shares of the company’s stock, valued at approximately $101,827.32. The trade was a 62.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.
Plexus Price Performance
Shares of PLXS opened at $139.19 on Friday. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $172.89. The company has a market capitalization of $3.76 billion, a price-to-earnings ratio of 32.29 and a beta of 0.89. The firm has a 50-day simple moving average of $155.93 and a 200-day simple moving average of $144.27. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.70 and a current ratio of 1.53.
Plexus (NASDAQ:PLXS – Get Free Report) last announced its earnings results on Wednesday, January 22nd. The technology company reported $1.49 earnings per share for the quarter, missing the consensus estimate of $1.59 by ($0.10). Plexus had a return on equity of 10.36% and a net margin of 3.03%. On average, equities research analysts anticipate that Plexus Corp. will post 5.94 earnings per share for the current year.
Institutional Investors Weigh In On Plexus
Analyst Upgrades and Downgrades
A number of equities analysts recently commented on PLXS shares. KeyCorp assumed coverage on shares of Plexus in a research note on Tuesday, October 22nd. They set a “sector weight” rating for the company. Stifel Nicolaus assumed coverage on shares of Plexus in a research note on Tuesday, February 4th. They issued a “hold” rating and a $152.00 price objective for the company. Benchmark restated a “buy” rating and issued a $165.00 price objective on shares of Plexus in a research note on Wednesday, January 22nd. Needham & Company LLC upped their price objective on shares of Plexus from $162.00 to $172.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Finally, StockNews.com upgraded shares of Plexus from a “hold” rating to a “buy” rating in a research note on Monday, November 18th. Two research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $163.00.
View Our Latest Stock Analysis on PLXS
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Recommended Stories
- Five stocks we like better than Plexus
- Where to Find Earnings Call Transcripts
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What is a Special Dividend?
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- How to Profit From Growth Investing
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.